Aetiology and management of hypertrophic scars and keloids

Annals of the Royal College of Surgeons of England

Volumn 78, Issue 3 Part I, 1996, Pages 168-175

  O'Sullivan, S T ^a   O'Shaughnessy, M ^a   O'Connor, Tpf ^a  

^a Cork University Hospital ^*  (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; HUMAN; HYPERTROPHIC SCAR; KELOID; PATHOPHYSIOLOGY; REVIEW;

CICATRIX, HYPERTROPHIC; HUMANS; KELOID;

EID: 9344254351     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Oluwasanami JO. Keloids in the African. Clin Plast Surg 1974; 1: 179-95.
2. Retz N. Des maladies de la peau et des celles de l'esprit, 3rd Edition, Paris: Mequinon, 1790.
3. Alibert JLM. Quelques recherches sur la cheloide. Mem Soc Medicale d'Emulation 1817: 744.
4. Muir IFK. On the nature of keloid and hypertrophic scars. Br J Plast Surg 1990; 43: 61-9.
5. Peacock EE Jr, Madden JW, Trier WC. Biological basis for treatment of keloids and hypertrophic scars. South Med J 1970; 63: 755-60.
6. Russell SB, Trupin KM, Rodriguez-Eaton S, Russell JD. Reduced growth factor requirement of keloid-derived fibroblasts may account for tumor growth. Proc Natl Acad Sci USA 1988; 85: 587-91.
7. Dubato-Brown DD. Keloids: a review of the literature. Br J Plast Surg 1990; 43: 70-7.
8. Koonin AJ. The aetiology of keloids: a review of the literature and a new hypothesis. S Afr Med J 1964; 38: 913-16.
9. Cosman B, Crickelair GF, Ju MC, Gaulin JC, Lanes R. The surgical treatment of keloids. Plast Reconstr Surg 1961; 27: 335-8.
10. Ramakrishnan KM, Thomas KP, Sundararajan CR. Study of 1000 patients with keloids in South India. Plast Reconstr Surg 1974; 53: 276-80.
11. Edington GM, Gilles HM. Pathology in the Tropics. London: Edward Arnold, 1969.
12. Murray JC, Pollack SV, Pinnell SR. Keloids: a review. J Am Acad Dermatol 1981; 4: 461-70.
13. Bloom D. Heredity of keloids: a review of the literature and report of a family with multiple keloids in five generations. N Y State Med J 1956; 56: 511-19.
14. Gominne L. A new probably X-linked inherited syndrome: congenital muscular torticollis, multiple keloids, cryptorchidism and renal dysplasia. Acta Genet Med 1968; 17: 439-41.
15. Laurenataci G, Dioguardi D, HLA antigens in keloids and hypertrophic scars. Arch Dermatol 1977; 113: 1726-30.
16. Cohen IK, McCoy BJ, Mohanakumar T, Diegelmann RP. Immunoglobulin, complement and histocompatibility antigen studies in keloid patients. Plast Reconstr Surg 1979; 63: 689-35.
17. Davey WW. Companion to Surgery in Africa. Edinburgh: Churchill Livingstone, 1968.
18. Shukla IM, Arora NP, Arora MM. Corneal keloids. Indian J Ophthalmol 1975; 23: 18.
19. LeMasters WC, Notz RG. Corneal keloids. Trans Pa Acad Ophthalmol Otolaryngol 1986; 38: 286.
20. Ronnenn M, Sokol MS, Huszar M, Kahana M, Schewach-Miller M. Pseudomelanoma following treatment with surgical excision and intralesional triamcinolone acetonide to prevent keloid formation. Int J Dermatol 1986; 25: 533-4.
21. Hiss Y, Shafir R. Tseudomelanoma' in a keloid. J Dermatol Surg Oncol 1978; 4: 938-9.
22. Novick NL, Lawson W, Schwartz IS. Suppurative keloidosis in a black woman. J Am Acad Dermatol 1986; 15: 1090-2.
23. Kurwa AR. Rubenstein-Taybi syndrome and spontaneous keloids. Clin Exp Dermatol 1979; 4: 251-4.
24. Hunt TK. Fundamentals of Wound Management in Surgery. Wound Healing: Normal Repair. South Plainfield NJ, USA: Chimrgecom, 1976.
25. Cuono CB. Scars and keloids. In: Jurkiewicz MJ, Krizek TJ, Mathes SJ, Ariyan S, eds. Plastic Surgery: Principles and Practice. St Louis: CV Mosby, 1990.
26. Shakespeare PG, Strange RE. Linoleic acid in hypertrophic scars. Burns 1982; 9: 7-12.
27. Knighton DR, Hunt TK, Thakral KK, Goodson WH. Role of platelets and fibrin in the healing sequence. Ann Surg 1982; 196: 379-88.
28. Hakanson R, Owman C, Sjoberg NO. Direct histochemical demonstration of histamine in cutaneous mast cells: urticaria pigmentosa and keloids. Experientia 1969; 25: 854-5.
29. Cohen IK, Beaven MA, Horakova Z, Keiser HR. Histamine and collagen synthesis in keloids and hypertrophic scars. Surg Forum 1972, 23: 509-10.
30. Boucek RJ, Nobel NL. Histamine, norepinephrine and bradykinin stimulation of fibroblast growth and modification of serotonin response. Proc Soc Exp Biol Med 1973; 144: 929-33.
31. Topol BM, Lewis VL, Benveniste K. The use of antihistamine to retard the growth of fibroblasts derived from human skin, scar and keloid. Plast Reconstr Surg 1981; 68: 227-32.
32. Diegelmann RF, Cohen IK, McCoy BJ. Growth kinetics and collagen synthesis of normal skin, normal scar and keloid fibroblasts in vitro. J Cell Physiol 1979; 98: 341-6.
33. Bazin S, Bailey AJ, Nicoletis C, Delaunaya A. Biochemical composition and molecular structure of the intercellular matrix in human hypertrophic scars. Transactions of the International Symposium in Wound Healing. Rotterdam, Netherlands, 1974.
34. Ala-Kokko L, Rintala A, Savolainen ER. Collagen gene expression in keloids: analysis of collagen metabolism and type I, III, FV, V procollagen mRNAs in keloid tissue and keloid fibroblast cultures. J Invest Dermatol 1987; 89: 238-44.
35. Cohen IK, Keiser HR, Sjoerdsma A. Collagen synthesis in human keloid and hypertrophic scar. Surg Forum 1971; 22: 488-9.
36. Harris ED Jr, Sjoerdsma A. Collagen profile in various clinical conditions. Lancet 1966; 2: 707-11.
37. Weber L, Meigel WN, Speir W. Collagen polymorphism in pathologic human scars. Arch Dermatol Res 1978; 261: 63-71.
38. Placik OJ, Lewis VL Jr. Immunologic associations of keloids. Surg Gynecol Obstet 1992; 175: 185-93.
39. Abergel RP, Pizzuro D, Meeker CA et al. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol 1985; 84: 384-90.
40. Uitto J, Perejda AJ, Abergel RP, Chu ML, Ramirez F. Altered steady state ratio of type I/III procollagen mRNAs correlates with selectively increased type I procollagen biosynthesis in cultured keloid fibroblasts. Proc Natl Acad Sci U S A 1985; 82: 5935-9.
41. Uitto J, Murray LW, Blumberg B, Shamban A. Biochemistry of collagen in diseases. Ann Intern Med 1986; 105: 740-6.
42. Friedman DW, Boyd CD, Mackenzie JW, Norton P, Olson RM, Deak SB. Regulation of collagen gene expression in keloids and hypertrophic scars. J Surg Res 1993; 55: 214-22.
43. 1(I) collagen gene enhance transcription. J Biol Chem 1987; 262: 151-6.
44. 2(I) collagen gene: functional deletion analysis of the promoter and evidence for cell-specific expression. Mol Cell Biol 1986; 6: 347-54.
45. 2(I) collagen gene. Proc Natl Acad Sci U S A 1987; 84: 5590-4.
46. Ketchum LD, Cohen IK, Masters FW. Hypertrophic scars and keloids: a collective review. Plast Reconstr Surg 1974; 53: 140-54.
47. Knapp TR, Daniels RJ, Kaplan EN. Pathologic scar formation: morphologic and biochemical correlates. Am J Pathol 1977; 86: 47-70.
48. Moulton-Levy P. Multiple cell origin of traumatically induced keloids. J Am Acad Dermatol 1984; 10: 986-8.
49. Cohen IK, Diegelmann RF, Bryant CP. Alpha globulin collagenase inhibitors in keloid and hypertrophic scar. Surg Forum 1975; 26: 61-2.
50. de Limpens JAM, Cormane RH. Keloids and hypertrophic scars: immunological aspects. Aesthetic Plast Surg 1982; 6: 149-52.
51. de Limpens JAM, Cormane RH. Studies on immunologic aspects of keloids and hypertrophic scars. Arch Dermatol Res 1982; 274: 259-63.
52. Kischer CW, Shetlar MR, Shetlar CL, Chvapil M. Immunoglobulins in hypertrophic scars and keloids. Plast Reconstr Surg 1983; 71: 821-5.
53. Bornstein P, Sage H. Regulation of collagen gene expression. Prog Nucleic Acid Res Mol Biol 1989; 37: 67-106.
54. McCauley RL, Chopra V, Li YY et al. Altered cytokine production in black patients. Presented at the 37th Annual Meeting of Plastic Surgery Research Council. Toronto, Ontario, April 1992.
55. Wahl SM, Gately CL. Modulation of fibroblast growth by a lymphokine of human T cell and continuous T cell line origin. J Immunol 1982; 130: 1226-30.
56. Russell SB, Trupin KP, Rodriguez-Eaton S et al. Reduced growth-factor requirement of keloid-derived fibroblasts may account for tumor growth. Proc Natl Acad Sci USA 1988; 85: 587-91.
57. Moustafa MFH, Abdel Fattah AF. Presumptive evidence of the effect of pregnancy estrogens and keloid growth: a case report. Plast Reconstr Surg 1975; 56: 450-3.
58. Sharma BC. Keloids: a prospective study of 57 cases. Med J Zambia 1980; 14: 66-8.
59. Harvey-Kemble JV. The management of scars, hypertrophic scars and keloids. Surgery 1988; 54: 1286-9.
60. Huang TT, Blackwell SJ, Lewis SR. Ten years of experience in managing patients with bum contractures of axilla, elbow, wrist and knee joints. Plast Reconstr Surg 1978; 61: 70-6.
61. Evans DB. Prevention and correction of deformity after severe bums. Surg Clin North Am 1970; 50: 1361-74.
62. Larson DL. Techniques for decreasing scar formation and contractures in the burned patient. J Trauma 1971; 11: 807-11.
63. Brent B. The role of pressure therapy in management of earlobe keloids: preliminary report of a controlled study. Ann Plast Surg 1978; 1: 579-81.
64. Sela M, Taicher S. Prosthetic treatment of earlobe keloids. J Prosthet Dent 1984; 32: 417-18.
65. Perkins K, Davey RB, Wallis KA. Silicone gel: a new treatment for bum scars and contractures. Burns 1982; 9: 406-10.
66. Gold MH. Topical silicone gel sheeting in the treatment of hypertrophic scars and keloids: a dermatologic experience. J Dermatol Surg Oncol 1993; 19: 912-16.
67. Quinn KJ. Silicone gel in scar treatment. Burns 1987; 13: 833-40.
68. Swanson JW, LeBeau JE. The effect of implantation on the physical properties of silicone rubber. J Biomed Mater Res 1974; 8: 357.
69. Ahn ST, Monafo WW, Mustoe TA. Topical silicone gel: a new treatment for hypertrophic scars. Surgery 1989; 106: 781-7.
70. Ann ST, Monafo WW, Mustoe TA. Topical silicone gel for the prevention and treatment of hypertrophic scar. Arch Surg 1991; 126: 499-504.
71. Katz BE. Silastic gel sheeting is found to be effective in scar therapy. Cosm Dermatol 1992; 5: 1-3.
72. Sawada Y, Sone K. Hydration and occlusion treatment for hypertrophic scars and keloids. Br J Plast Surg 1992; 45: 599-603.
73. Sawada Y, Sone K. Beneficial effects of silicone cream on grafted skin. Br J Plast Surg 1992; 45: 105-8.
74. Kischer CW, Bunce H, Shetler MR. Mast cell analyses in hypertrophic scars, hypertrophic scars treated with pressure and mature scars. J Invest Dermatol 1978; 70: 355-7.
75. Sloan DF, Brown RD, Wils CH, Hilton JG. Tissue gases in human hypertrophic bum scars. Plast Reconstr Surg 1978; 61: 431-6.
76. Muti E, Ponzio E. Cryotherapy in the treatment of keloids. Minerva Chir 1983; 38: 1003-6.
77. Shepherd JP, Dawber RF. The response of keloid scars to Cryotherapy. Plast Reconstr Surg 1982; 70: 677-82.
78. Hirshowitz B, Lerner D, Moscona AR. Treatment of keloid scars by combined cryotherapy and intralesional corticosteroids, Aesthetic Plast Surg 1982; 6: 153-8.
79. Apfelberg DB, Maser MR, Lash H, White D, Weston J. Preliminary results of argon and carbon dioxide laser treatment of keloid scars. Lasers Surg Med 1984; 4: 283-90.
80. Abergel RP, Dwyer RM, Meeker CA, Lask G, Kelly AP, Uitto J. Laser treatment of keloids: a clinical trial and an in vitro study with Nd:YAG laser. Lasers Surg Med 1984; 4: 291-5.
81. Leavitt WM, Gilles H. Radiotherapy in the prophylaxis and treatment of keloids. Lancet 1942; 1: 440.
82. Levy DS, Salter MM, Roth RE. Postoperative irradiation in the prevention of keloids. AJR 1976; 127: 509-11.
83. Malaker K, Ellis F, Paine C. Keloid scars: a new method of treatment combining surgery with interstitial radiotherapy. Clin Radiol 1976; 27: 179.
84. Hoffman S. Radiotherapy for keloids. Ann Plast Surg 1982; 9: 262-5.
85. Mayou BJ. D-Penicillamine in the treatment of keloids. Br J Dermatol 1981; 105: 87-9.
86. Edgerton MT, Hanrahan EM, Davis WB. Use of vitamin E in the treatment of keloids. Plast Reconstr Surg 1951; 8: 224-7.
87. Peacock EE. Pharmacologic control of surface scarring in human beings. Ann Surg 1981; 193: 592-7.
88. Hein RR, Meusing H, Muller PK, Braun-Falco O, Kreig T. Effect of vitamin A and its derivatives on collagen production and chemotactic response of fibroblasts. Br J Dermatol 1984; 111: 37-44.
89. Chiu HC, Wu YC, Lu YC. Effects of dextran sulphate on the growth of cultured fibroblasts derived from normal human skin and keloid lesions. J Formosan Med Assoc 1987; 86: 264.
90. Murray JC, Pollack SV, Pinnell SR. Keloids: a review. J Am Acad Dermatol 1981; 4: 461-70.
91. Nelson DL, Balian G. The effect of retinoic acid on collagen synthesis by human dermal fibrofalasts. Coll Relat Res 1984; 4: 119-28.
92. McGuire HC. Treatment of keloids with triamcinolonc acetonide injected intralesionally. JAMA 1965; 192: 325-9.
93. Ketchum LD. Treatment of hypertrophic scars, keloids and scar contracture by triamcinolone acetonide. Plast Reconstr Surg 1966; 38: 209-14.
94. Murray RD. Kenalog and the treatment of hypertrophic scars and keloids in Negroes and whites. Plast Recoknstr Surg 1963; 31: 275.
95. Russell SB, Russell JD, Tnipin JS. Alteration of amino acid transport by hydrocortisone. J Biol Chem 1982; 257: 9525-31.
96. Gadson PF, Russell JD, Russell SB. Glucocorticoid receptors in human fibroblasts derived from human fibroblasts derived from normal dermis and keloid tissue. J Biol Chem 1984; 259: 11236-41.
97. Thompson J, Crumley R. Facial plastic news: research advances. Arch Otolaryngol Head Neck Surg 1990; 116: 768-9.
98. Larrabee WF Jr, East CA, Jaffee HS et al. Intralesional interferon-gamma treatment of keloids and hypertrophic scars. Arch Otolaryngol Head Neck Surg 1990; 116: 1159-62.
99. Granstein RD, Rook A, Flotte TJ et al. A controlled trial of intralesional interferon-gamma in the treatment of keloidal scarring. Clinical and histologic findings. Arch Dermatol 1990; 126: 1295-1302.
100. Berman B, Duncan MR. Short-term keloid treatment in vivo with human interferon-alpha-2b results in a selective and persistent normalization of keloid fibroblast collagen, glycosaminoglycan, and collagenase production in vitro. J Am Acad Dermatol 1989; 21: 694-702.